Principles of pharmacokinetics Flashcards

1
Q

First pass effect

A

-metabolism from the gut and liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Gut absorption

A
  • absorbed by active transport, passive diffusion and pore filtration
  • factors influencing the absorption of drugs include intestinal motility, gastric emptying,ph, intestinal flora, area available for absorbption, blood flow and presence or absence of food
  • p-glycoprotein transports some drugs- inhibted by grapefruit juice
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

IM administration

A
  • lipid soluble drugs are rapidly absorbed

- drugs of low molecular weight are better absorbed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Protein binding

A
  • distribution of a drug depends on how protein bound it is
  • it is the unbound fraction (free) that can be active
  • plasma protein binding is usually reversible
  • highly protein bound drugs such as phenytoin are most prone to interactions mediated by this mechanism
  • principle protein binding for acidic drugs is albumin with alpha 1 acid glucoprotein is the primary binding protein for alkaline drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Blood brain barrier

A
  • affecte by fever, head injury, hypoxia, hypercapnia, retrioviruses, inflammation, vasculitis, hypertension, cerebral irradiation and aging
  • unionised molecules and less protein bound so they are transported across the barrier easily
  • small, lipophilic molecules or those with transporters
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Bioequivilance

A

-measure of comparability of plasma levels of two different formulations of the same active compound when given at same dose and the same route of administration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Half life

A

refers to the time taken for the plasma concentration of a drug to halve

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

First order kinetics

A

when a constant fraction of drug is cleared per unit time

  • the higher the amount of drug present the faster the elimation
  • rate depends on concentration
  • not dependent on any other rate-limiting step
  • constant half life
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Zero order kinetics

A
  • constant amount of drug is cleared per unit time- not fraction
  • the body only clears a fixed amount of the drug regardless of concentration
  • increasing the dose might result in serious toxicity
  • half life depends on dose
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Loading dose

A

help to achieve steady state more rapidly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Steady state

A

when rate in is the same as rate out and the plasma level is constant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Changes in pregnancy

A
  • delayed gastric emptying
  • decreased GIT motility
  • increased volume of distribution
  • decreased drug-binding capacity
  • decreased albumin level
  • induced liver metabolic pathway
  • increased GFR and renal clearance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Changes in elderly

A
  • decrease in body water and increase in fat-longer half life
  • decreased plasma protein binding
  • hepatic metabolism remains the same but blood flow may reduce
  • decreases in renal blood flow and reduce Cr clearance and GF
  • absorption remains the same
  • decreased number of brain acetylcholine postsynaptic receptors and acetylcholinesterase also decreased
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Neonates

A
  • neonates have a higher proportion of total body water and extracellular body water
  • neonates have a lower proportion of adipose tissue
  • eGFR Is lower in those under 5 months
  • neonates have lower gastric acidity and increased gastric emptying time
  • more permeable BBB
  • lower plasma conc of albumin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Renal impairment

A

-use benzos with caution- halve dose of lorazepam
0imipramine and amitriptyline can be given with usual dosage
-halve dose of citalopram
-dont use sertraline
-haloperidol can be used normally
-dont use amisulpride
-lithium best avoided

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

TCAs

A
  • steady stae reached at 5-7 days
  • reach peak plasma concen 1-12 hrs
  • increase warfarin levels
  • decrease the metabolism of morphine and increae opioid toxicity
17
Q

SSRIs

A
  • most protein bound except ecitalopram
  • citalopram is most selective, paroxetine is most potent
  • citaloprami smetabolised by CYP2C19 and then CYP2D6
  • CYP33 and CYP3A4 are responsible for sertraline
  • all interact with TCAs
18
Q

MAOIs

A
  • all rapidly absorbed
  • pethidine is very bad with MAO
  • amphetamine is also very bad but methylpgebudate is ok
19
Q

Busiprone

A
  • short half life of 2-11 hours
  • given 3x daily
  • active metabolite is 1-PP
  • acts as a partial agonist on serotonin 5-HT1A receptors
  • pre-synaptic agonism leads to inhibition of release of serotoin
20
Q

Trazodone and nefazodone

A
  • half life 5-9 hours
  • antagonist of seotonin 5-HT2A nd 2C receptors
  • half life 14 hours
  • active metaboite is mCPP- can cause migraine, anxiety and weightloss
  • acute sedative effect
  • increases levels of digoxin and phenytoin and warfarin
21
Q

Venlafaxine

A
  • low protein binding
  • t 1/2 pf 3.5 houts
  • well absorbed orally
  • no enzyme inducing properties
  • CYP2D6
22
Q

Mirtazapine

A
  • reaches peak plasma concentrations within 2 hours
  • bioavailability of 50% due to first past metabolism
  • 1st order kinetcis
  • t 1/2 20-40 hrs
  • metabolism by CYP2D6 and CYP3A4
  • thus paroxetine and fluoxetine which inhibit the CYP system increase plasma concentrations
  • carbamazepine causes 60% decrease in plasma concentrations
  • mirtazapine has no inhibitory effects of CYP isoenzymes
23
Q

St JOhn’s wart

A
  • CYP inducer
  • can interact with warfarin, OCPs and antiepileptics, decreasing their efficacy
  • acts via multiple monoamine reuptake inhibition